Gencove is at the forefront of genomic technology, providing comprehensive solutions that span human, plant, and animal genomics. Their platform enables whole genome sequencing at a cost comparable to traditional genotyping arrays, facilitating high-powered genome-wide association studies and the prediction of genetic disease risks. Gencove's technology allows for the design of targeted assays for population health screening and the identification of genetic traits, ancestry, and parentage across various species. This versatility is crucial for advancing research in diverse fields, from healthcare to agriculture.

The Gencove Explorer analysis cloud enhances the efficiency of genomic data processing and management, allowing scientists to focus on biological inquiries rather than the complexities of computational infrastructure. This platform streamlines workflows, automates routine processes, and maximizes the value of genetic data while ensuring user autonomy and data privacy. By integrating high- and medium-density genotyping into a single scalable solution, Gencove empowers researchers to profile genetic variation, predict breeding values, and track trait introgression effectively, thereby accelerating the journey from samples to actionable insights.

United States

Gencove creates high-volume, cost-sensitive sequencing software-as-a-service to help academic, agriculture, biotech, diagnostic, and pharmaceutical companies get all the genomic information they need to make life-saving discoveries.

Gencove

Company Details